Cargando…

Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy

BACKGROUND: Post-infectious glomerulonephritis (PIGN) is an immune complex-mediated glomerular injury that typically resolves. Dominant C3 deposition is characteristic of PIGN, but with the emergence of C3 glomerulonephritis (C3GN) as a distinct entity, it is unclear how the pathologic similarities...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalighi, Mazdak A., Wang, Shihtien, Henriksen, Kammi J., Bock, Margret, Keswani, Mahima, Meehan, Shane M., Chang, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886922/
https://www.ncbi.nlm.nih.gov/pubmed/27274823
http://dx.doi.org/10.1093/ckj/sfw032
_version_ 1782434667963613184
author Khalighi, Mazdak A.
Wang, Shihtien
Henriksen, Kammi J.
Bock, Margret
Keswani, Mahima
Meehan, Shane M.
Chang, Anthony
author_facet Khalighi, Mazdak A.
Wang, Shihtien
Henriksen, Kammi J.
Bock, Margret
Keswani, Mahima
Meehan, Shane M.
Chang, Anthony
author_sort Khalighi, Mazdak A.
collection PubMed
description BACKGROUND: Post-infectious glomerulonephritis (PIGN) is an immune complex-mediated glomerular injury that typically resolves. Dominant C3 deposition is characteristic of PIGN, but with the emergence of C3 glomerulonephritis (C3GN) as a distinct entity, it is unclear how the pathologic similarities between PIGN and C3GN should be reconciled. Therefore, nephrologists and nephropathologists need additional guidance at the time of biopsy. METHODS: We studied 23 pediatric and young adult patients diagnosed with PIGN. Patients were divided into two groups, one with co-dominance between C3 and immunoglobulins and the other meeting proposed diagnostic criteria for C3GN. Clinical and pathological features were compared. RESULTS: No clinical and/or pathological features could distinguish between those with C3-co-dominant deposits and those with C3 dominance. Nearly all patients in both groups regained their baseline renal function without clinical intervention. CONCLUSIONS: Although the identification of abnormalities of the alternative pathway of complement is characteristic of C3GN, testing is not widely available and the turnaround time often exceeds 1 month. Our study found that PIGN with either co-dominant or dominant C3 deposition in a cohort of young patients has excellent short-term outcomes. Close clinical observation for persistent abnormalities, such as hypocomplementemia, prolonged hematuria or proteinuria, is recommended to single out patients that may harbor intrinsic complement abnormalities.
format Online
Article
Text
id pubmed-4886922
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-48869222016-06-03 Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy Khalighi, Mazdak A. Wang, Shihtien Henriksen, Kammi J. Bock, Margret Keswani, Mahima Meehan, Shane M. Chang, Anthony Clin Kidney J Glomerulonephritis BACKGROUND: Post-infectious glomerulonephritis (PIGN) is an immune complex-mediated glomerular injury that typically resolves. Dominant C3 deposition is characteristic of PIGN, but with the emergence of C3 glomerulonephritis (C3GN) as a distinct entity, it is unclear how the pathologic similarities between PIGN and C3GN should be reconciled. Therefore, nephrologists and nephropathologists need additional guidance at the time of biopsy. METHODS: We studied 23 pediatric and young adult patients diagnosed with PIGN. Patients were divided into two groups, one with co-dominance between C3 and immunoglobulins and the other meeting proposed diagnostic criteria for C3GN. Clinical and pathological features were compared. RESULTS: No clinical and/or pathological features could distinguish between those with C3-co-dominant deposits and those with C3 dominance. Nearly all patients in both groups regained their baseline renal function without clinical intervention. CONCLUSIONS: Although the identification of abnormalities of the alternative pathway of complement is characteristic of C3GN, testing is not widely available and the turnaround time often exceeds 1 month. Our study found that PIGN with either co-dominant or dominant C3 deposition in a cohort of young patients has excellent short-term outcomes. Close clinical observation for persistent abnormalities, such as hypocomplementemia, prolonged hematuria or proteinuria, is recommended to single out patients that may harbor intrinsic complement abnormalities. Oxford University Press 2016-06 2016-05-17 /pmc/articles/PMC4886922/ /pubmed/27274823 http://dx.doi.org/10.1093/ckj/sfw032 Text en © The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Glomerulonephritis
Khalighi, Mazdak A.
Wang, Shihtien
Henriksen, Kammi J.
Bock, Margret
Keswani, Mahima
Meehan, Shane M.
Chang, Anthony
Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy
title Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy
title_full Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy
title_fullStr Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy
title_full_unstemmed Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy
title_short Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy
title_sort revisiting post-infectious glomerulonephritis in the emerging era of c3 glomerulopathy
topic Glomerulonephritis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886922/
https://www.ncbi.nlm.nih.gov/pubmed/27274823
http://dx.doi.org/10.1093/ckj/sfw032
work_keys_str_mv AT khalighimazdaka revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy
AT wangshihtien revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy
AT henriksenkammij revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy
AT bockmargret revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy
AT keswanimahima revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy
AT meehanshanem revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy
AT changanthony revisitingpostinfectiousglomerulonephritisintheemergingeraofc3glomerulopathy